Presentation ESC 2017 The Viborg Vascular (VIVA) Randomised Screening Trial Presenter: Jes Lindholt August 29, 2017
Presentation ESC 2017 Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-Segment Elevation Presenter: Borja Ibanez August 28, 2017
Presentation ESC 2017 DETermination of the role of OXygen in suspected Acute Myocardial Infarction Presenter: Robin Hofmann August 28, 2017
Presentation ESC 2017 PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease Presenter: Martin J. Holzmann August 28, 2017
Presentation ESC 2017 Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial Presenter: Robert Giugliano August 28, 2017
Presentation ESC 2017 Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease Presenter: Paul M. Ridker August 27, 2017
Presentation ESC 2017 Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease Presenter: John Eikelboom August 27, 2017
Presentation ESC 2017 Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial Presenter: David Erlinge August 27, 2017
Presentation ESC 2017 Gender Differences in the Decrease of In-Hospital Mortality in Patients with Acute Myocardial Infarction Presenter: Dragana Radovanovic August 26, 2017
Presentation ESC 2017 Impact of BMI on Clinical Outcomes and Readmissions After Cardiac Catheterization Presenter: Afnan Tariq August 26, 2017